XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Paid-In Capital
Retained Earnings
Unearned ESOP Shares
Accumulated Other Comprehensive Loss
Balance at beginning of period (in shares) at Jun. 30, 2022   68,666,000        
Balance at beginning of period at Jun. 30, 2022 $ 894,000 $ 687 $ 528,396 $ 445,451 $ (24,807) $ (55,727)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (Loss) Income 18,486     18,486    
Other comprehensive income (loss), net of income tax (13,294)         (13,294)
ESOP shares committed to be released 1,079   106   973  
Stock repurchases (in shares)   (1,310,000)        
Stock repurchases (14,438) $ (14) (14,424)      
Issuance of stock under stock benefit plans (in shares)   61,000        
Issuance of stock under stock benefit plans 0 $ 1 (1)      
Stock-based compensation expense 1,596   1,596      
Cancellation of shares issued for restricted stock awards (in shares)   (29,000)        
Cancellation of shares issued for restricted stock awards (341)   (341)      
Cash dividends declared (14,448)     (14,448)    
Balance at end of period (in shares) at Dec. 31, 2022   67,388,000        
Balance at end of period at Dec. 31, 2022 872,640 $ 674 515,332 449,489 (23,834) (69,021)
Balance at beginning of period (in shares) at Sep. 30, 2022   67,938,000        
Balance at beginning of period at Sep. 30, 2022 874,974 $ 680 520,245 454,710 (24,321) (76,340)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (Loss) Income 1,951     1,951    
Other comprehensive income (loss), net of income tax 7,319         7,319
ESOP shares committed to be released 503   16   487  
Stock repurchases (in shares)   (550,000)        
Stock repurchases (5,745) $ (6) (5,739)      
Stock-based compensation expense 810   810      
Cash dividends declared (7,172)     (7,172)    
Balance at end of period (in shares) at Dec. 31, 2022   67,388,000        
Balance at end of period at Dec. 31, 2022 $ 872,640 $ 674 515,332 449,489 (23,834) (69,021)
Balance at beginning of period (in shares) at Jun. 30, 2023 65,864,075 65,864,000        
Balance at beginning of period at Jun. 30, 2023 $ 869,284 $ 659 503,332 457,611 (22,862) (69,456)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (Loss) Income (3,985)     (3,985)    
Other comprehensive income (loss), net of income tax 5,626         5,626
ESOP shares committed to be released 771   (202)   973  
Stock repurchases (in shares)   (1,505,000)        
Stock repurchases (11,240) $ (15) (11,225)      
Issuance of stock under stock benefit plans (in shares)   133,000        
Issuance of stock under stock benefit plans 0 $ 1 (1)      
Stock-based compensation expense 1,792   1,792      
Cancellation of shares issued for restricted stock awards (in shares)   (47,000)        
Cancellation of shares issued for restricted stock awards (399)   (399)      
Cash dividends declared $ (13,871)     (13,871)    
Balance at end of period (in shares) at Dec. 31, 2023 64,445,270 64,445,000        
Balance at end of period at Dec. 31, 2023 $ 847,978 $ 645 493,297 439,755 (21,889) (63,830)
Balance at beginning of period (in shares) at Sep. 30, 2023   65,132,000        
Balance at beginning of period at Sep. 30, 2023 849,534 $ 652 497,269 460,464 (22,375) (86,476)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (Loss) Income (13,827)     (13,827)    
Other comprehensive income (loss), net of income tax 22,646         22,646
ESOP shares committed to be released 391   (95)   486  
Stock repurchases (in shares)   (687,000)        
Stock repurchases (4,773) $ (7) (4,766)      
Stock-based compensation expense 889   889      
Cash dividends declared $ (6,882)     (6,882)    
Balance at end of period (in shares) at Dec. 31, 2023 64,445,270 64,445,000        
Balance at end of period at Dec. 31, 2023 $ 847,978 $ 645 $ 493,297 $ 439,755 $ (21,889) $ (63,830)